Randomized Phase II Trial of PET Scan-Directed Combined Modality Therapy in Esophageal Cancer

Diseases and Conditions Researched


What is the purpose of this trial?

To induce a pCR rate of 20% in PET scan non-responders treated with either induction FOLFOX or carboplatin/paclitaxel, who then cross over to the other regimen during radiotherapy.

Participation Guidelines

Age: 18 Years and older
Gender: Both

Click here for detailed participation information for this trial.

Sponsor: CALGB
Last Updated:
Study HIC#: 1204010075